CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed
Drug / intervention
Glargine insulin vs regular insulindrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00177398
NCT00177398Phase 4Completed
CompareCT.gov

The Effect of Insulin Glargine on Glycemic Control, Morbidity, and Length of Stay in Hospitalized Subjects With Diabetes Receiving Enteral Nutrition

University of Pittsburgh·interventional·Posted Sep 15, 2005·Updated Dec 19, 2007

In Brief

A Phase 4 clinical trial evaluating Glargine insulin vs regular insulin for Type 2 Diabetes and Hyperglycemia. Completed, across 1 site.

Detailed Summary

The purpose of this study is to determine if the early initiation of a long acting insulin (i.e. glargine) with supplemental doses of short acting regular (SSR) insulin in hospitalized patients with diabetes who are fed using tube feedings reduces the frequency of high and low blood sugar levels when compared to use of SSR insulin alone.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes, Hyperglycemia
CountriesUnited States
CollaboratorsSanofi

Timeline

Phase 4CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 15, 2005
Enrollment StartFeb 1, 2005
Study CompletionAug 1, 2006
TodayJul 2, 2026
Posted 20.8 years ago

Interventions

Glargine insulin vs regular insulindrug